Diphtheria-Tetanus-acellular Pertussis Vaccines
"Diphtheria-Tetanus-acellular Pertussis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.
| Descriptor ID |
D022681
|
| MeSH Number(s) |
D20.215.894.135.535.295 D20.215.894.691.263.290 D20.215.894.691.824.290 D20.215.894.815.149 D20.215.894.860.900.267
|
| Concept/Terms |
Diphtheria-Tetanus-acellular Pertussis Vaccines- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Diphtheria Tetanus acellular Pertussis Vaccines
- Pertussis Vaccines, Diphtheria-Tetanus-acellular
- Vaccines, Diphtheria-Tetanus-acellular Pertussis
- DTaP Vaccines
- Vaccines, DTaP
- DTaP Vaccine
- Vaccine, DTaP
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
This graph shows the total number of publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in this website by year, and whether "Diphtheria-Tetanus-acellular Pertussis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in Profiles.
-
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV. AIDS. 2023 12 01; 37(15):2305-2310.
-
Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy. Vaccine. 2021 08 09; 39(34):4793-4799.
-
A DTaP-IPV//PRP~T vaccine (Pentaxim): a review of 16 years' clinical experience. Expert Rev Vaccines. 2011 Jul; 10(7):981-1005.
-
Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011 Apr; 30(4):e68-74.
-
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.